A Study of Pegylated Liposomal Doxorubicin and Cyclophosphamide in Her2-negative Stage I and II Breast Cancer Patients

This study is currently recruiting participants.
Verified June 2013 by TTY Biopharm
Sponsor:
Information provided by:
TTY Biopharm
ClinicalTrials.gov Identifier:
NCT01210768
First received: August 31, 2010
Last updated: June 4, 2013
Last verified: June 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: August 2018
  Estimated Primary Completion Date: July 2018 (Final data collection date for primary outcome measure)